🇺🇸 FDA
Company

Aardvark

Aardvark Therapeutics

AARD pharma USA

Quick answer

Aardvark is a pharma company (AARD) headquartered in SAN DIEGO, CA, USA with 6 tracked pipeline programs.

Pipeline (6)

project

ARD-101

Hyperphagia

Phase 3 · small_molecule · on_hold

1 trials project

Placebo

Hyperphagia

Phase 3 · small_molecule · on_hold

1 trials project

ARD-101

Bariatric Surgery

Phase 2 · small_molecule · completed

1 trials project

ARD-101

Obesity

Phase 2 · small_molecule · completed

1 trials project

ARD-101

Prader-Willi Syndrome

Phase 2 · small_molecule · completed

1 trials project

Low Dose ARD-501

Autism Spectrum Disorder

Phase 2 · small_molecule · completed

1 trials

Patents (7)

patent

US 12427125

Method for treating SARS and treating or preventing ARDS

Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12414934

Combination therapies

Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12329739

Isoflavonoid compounds and methods for the treatment of cancer

Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12318364

Isoflavonoid compositions and methods for the treatment of cancer

Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12268660

Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension

Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12201593

Oral pharmaceutical formulations of bitter compounds for asthma

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10835505

Oral pharmaceutical formulation for weight loss, diabetes and related disorders

Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)